Walsh, Sebastian

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet

Dementia and Cognitive Impairment ResearchHearing Loss and Rehabilitation

Cited by 3,860

Changes in prevalence and incidence of dementia and risk factors for dementia: an analysis from cohort studies

Mukadam, N., Wolters, F. J., Walsh, S., Wallace, L., Brayne, C., Matthews, F. E., Sacuiu, S., Skoog, I., Seshadri, S., Beiser, A., et al. (2024) · The Lancet Public Health

Dementia and Cognitive Impairment ResearchMenopause: Health Impacts and Treatments

Cited by 136

Lecanemab for Alzheimer’s disease

Walsh, S., Merrick, R., Richard, E., Nurock, S., & Brayne, C. (2022) · BMJ

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 76

The relevance of social and commercial determinants for neurological health

Walsh, S., Merrick, R., & Brayne, C. (2022) · The Lancet Neurology

Public Health and Social InequalitiesHealth disparities and outcomes

Cited by 55

Population-level interventions for the primary prevention of dementia: a complex evidence review

Walsh, S., Wallace, L., Kuhn, I., Mytton, O., Lafortune, L., Wills, W., Mukadam, N., & Brayne, C. (2024) · eClinicalMedicine

Dementia and Cognitive Impairment ResearchHealth Promotion and Cardiovascular Prevention

Cited by 43

A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia

Walsh, S., Brain, J., Mukadam, N., Anderson, R., Greene, L., Govia, I., Kuhn, I., Anstey, K. J., Knapp, M., Stephan, B. C. M., et al. (2022) · Maturitas

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 33

Evaluation of clinical benefits of treatments for Alzheimer's disease

Liu, K. Y., Walsh, S., Brayne, C., Merrick, R., Richard, E., & Howard, R. (2023) · The Lancet Healthy Longevity

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 31

France removes state funding for dementia drugs

Walsh, S., King, E., & Brayne, C. (2019) · BMJ

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 25

Benefits of population-level interventions for dementia risk factors: an economic modelling study for England

Mukadam, N., Anderson, R., Walsh, S., Wittenberg, R., Knapp, M., Brayne, C., & Livingston, G. (2024) · The Lancet Healthy Longevity

Health Systems, Economic Evaluations, Quality of LifeDementia and Cognitive Impairment Research

Cited by 24

What is a population-level approach to prevention, and how could we apply it to dementia risk reduction?

Walsh, S., Wallace, L., Mukadam, N., Mytton, O., Lafortune, L., Wills, W., & Brayne, C. (2023) · Public Health

Dementia and Cognitive Impairment ResearchPublic Health Policies and Education

Cited by 17